Correspondence to Dr Anne M van der Does, Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands; a.van_der_does{at}lumc.nl The lung epithelium has long been overlooked ...
Greg Daugherty has worked 25+ years as an editor and writer for major publications and websites. He is also the author of two books. Katie Miller is a consumer financial services expert. She worked ...
A global pharmaceutical company based in India has committed to a major investment in a UAB startup working to pioneer breakthrough FDA-approved therapeutics for lung diseases. Shilpa Medicare Limited ...
(BSE: 524742) (NSE: SHILPAMED), a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation. * Shilpa Medicare Serves as ...
CAMBRIDGE, Mass. and BIRMINGHAM, Ala. and RAICHUR, India, Aug. 4, 2025 /PRNewswire/ -- Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The investment is part of a ...
ACT: Activation-induced T-cell derived and chemokine related; BCA: B cell-attracting chemokine; BLC: B-lymphocyte chemoattractant; BRAK: Breast and kidney-expressed chemokine; CTACK: Cutaneous ...
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
School of Medical Technology, Beijing Institute of Technology, Beijing 100081, P. R. China School of Medical Technology, Beijing Institute of Technology, Beijing 100081, P. R. China Tangshan Research ...
COVID-19 vaccination has been the subject of immense scrutiny and misinformation since the vaccines were first administered in the U.S. nearly four years ago. In the first year alone, it is estimated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results